DETERMINENTS OF CORONARY DISEASE
冠心病的决定因素
基本信息
- 批准号:2227071
- 负责人:
- 金额:$ 25.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1994
- 资助国家:美国
- 起止时间:1994-04-15 至 1998-03-31
- 项目状态:已结题
- 来源:
- 关键词:angiography antiatherogenic agent atherosclerosis cholesterol esters computed axial tomography coronary disorder disease /disorder proneness /risk early diagnosis female gonadotropins heart disorder diagnosis high density lipoproteins human subject low density lipoprotein noninvasive diagnosis oxidized lipid postmenopause sex hormones ultrasonography women's health
项目摘要
The objective of this project is the identification of new biochemical
determinants of coronary disease in women based on recent advances in
understanding of the native molecular species of high density lipoproteins
(HDL), the function of HDL in the retrieval pathway of cholesterol, the
quantized subspeciation of low density lipoprotein (LDL), the ability of
HDL to inhibit the oxidation of LDL and their relationship to sex hormones
and their metabolites. Such knowledge can be expected to improve our
ability to identify women at risk for premature coronary disease an could
lead to new strategies of prevention and treatment that influence the
function of HDL species in specialized metabolic roles. The distribution
and architecture of coronary lesions in women at risk because of genetic
hypercholesterolemia will be studied by quantitative coronary angiography,
intracoronary ultrasonography and ultrafast computerized tomography to
establish in cross section, the natural history of developing lesions in
women and for study of their relationships to the lipoprotein parameters as
predictors of risk. Whereas ultracentrifugation long employed for HDL
studies deranges the architecture of native HDL species, the newly
developed technique of selected affinity immunosorption demonstrates the
existence of seven or more discrete species. The quantitative profile of
these species, the ability of HDL to prevent the oxidation of LDL and to
effect the transfer of cholesteryl esters to acceptor lipoproteins, a
process critical to the retrieval pathway for cholesterol, will be studied
as risk factors for coronary disease. Because of its potential
relationship to the cholesteryl ester transfer capability of HDL, the
particle size distribution of LDL will be measured.
该项目的目的是鉴定新的生化物质
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARY J MALLOY其他文献
MARY J MALLOY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARY J MALLOY', 18)}}的其他基金
ANTIATHEROGENIC EFFECTS OF MODERATE ALCOHOL USE
适量饮酒的抗动脉粥样硬化作用
- 批准号:
6168341 - 财政年份:1996
- 资助金额:
$ 25.43万 - 项目类别:
ANTIATHEROGENIC EFFECTS OF MODERATE ALCOHOL USE
适量饮酒的抗动脉粥样硬化作用
- 批准号:
2769196 - 财政年份:1996
- 资助金额:
$ 25.43万 - 项目类别:
ANTIATHEROGENIC EFFECTS OF MODERATE ALCOHOL USE
适量饮酒的抗动脉粥样硬化作用
- 批准号:
2000781 - 财政年份:1996
- 资助金额:
$ 25.43万 - 项目类别:
ANTIATHEROGENIC EFFECTS OF MODERATE ALCOHOL USE
适量饮酒的抗动脉粥样硬化作用
- 批准号:
2516856 - 财政年份:1996
- 资助金额:
$ 25.43万 - 项目类别:
ANTIATHEROGENIC EFFECTS OF MODERATE ALCOHOL USE
适量饮酒的抗动脉粥样硬化作用
- 批准号:
2894157 - 财政年份:1996
- 资助金额:
$ 25.43万 - 项目类别:
LIPOPROTEIN STRUCTURES IN CHILDREN AND ADULTS--HYPO- AND HYPERLIPOPROTEINEMIAS
儿童和成人的脂蛋白结构——低脂蛋白血症和高脂蛋白血症
- 批准号:
4700325 - 财政年份:
- 资助金额:
$ 25.43万 - 项目类别:
LIPOPROTEIN STRUCTURE STUDY IN HYPO AND HYPERLIPOPROTEINEMIAS
低脂蛋白血症和高脂蛋白血症的脂蛋白结构研究
- 批准号:
4704517 - 财政年份:
- 资助金额:
$ 25.43万 - 项目类别: